Collagen microcontact prints enable multiplexed assays in organotypic brain slice: Professor Christian Humpel and his team at the Medical University of Innsbruck, Austria have developed a practical, imaging‑friendly platform that brings precise spatial control to living brain slices. Working with 150‑micrometer organotypic mouse slices cultured at the membrane interface, they preserve native three‑dimensional circuitry while [...]

Miniaturized Telomerase Assays Reveal Novel Inhibitor Interactions: Telomerase reverse transcriptase (TERT) plays a central role in cellular development, regeneration, and cancer biology. Because abnormal telomerase activity is linked to tumor progression and age‑related diseases, researchers have long sought reliable ways to identify compounds that can modulate its function. Traditional assays, however, are limited in throughput [...]

Bioinstruments Customer Symposium at GeSiM, Radeberg: We are pleased to invite you to GeSiM’s 30-year anniversary celebration. It is the perfect occasion for a bioinstruments customer symposium, to be held close to our premises in Radeberg, Germany. Talk to customers and learn about their scientific work supported by GeSiM instruments. Event Dates: November 4–5, 2025 [...]

Self-Healing Ionogels Modeled After Spider Silk: Ionogels are three-dimensional polymer matrices infused with ionic liquids (ILs), offering unique properties such as high ionic conductivity, thermal and chemical stability, environmental resilience, and flexibility. Despite their advantages, ionogel-based devices are prone to damage and functional degradation over time, leading to reduced performance or failure. To address these [...]

GeSiM Partners with Yuri on Pioneering a 3D bioprinter for space: Yuri, a leading space biotechnology company, has initiated a groundbreaking project: the development of the first European 3D bioprinter for space. Specializing in the use of the microgravity environment of space to develop and manufacture superior biotech products, Yuri has consistently pushed the boundaries [...]

Precise DNA-Based Analysis for Pathogen Identification in Laboratory Medicine: The team of Cube Dx gathered experience with various technologies and instruments for DNA microarray production for laboratory medicine. Cylindrical microarrays – hybcells – are the core product of the IVD company. Cube Dx’ hybcells are a tool for sensitive and specific DNA-based identification of more [...]

Integrating FDM and Inkjet Printing for Personalized Drug-Loaded Tablets: The pharmaceutical field has witnessed a surge of interest in 3D printing (3DP) technologies, celebrated for their ability to create personalized, cost-effective, and complex oral dosage forms. Following the FDA’s approval of Aprecia Pharmaceutical’s Spritam® (levetiracetam) as the first 3D-printed tablet, the industry’s fascination with printable [...]

Long-Lasting Ocular Implants for Posterior Eye Diseases: Visual impairment and blindness are becoming a global issue due to their significant effects on social interactions and economic development. Diabetic retinopathy (DR) and age-related macular degeneration (AMD) are retinal disorders that are the main factors leading to blindness and vision impairment. As the elderly and diabetic populations [...]

Refining RPPA Techniques for Accurate Quantification of Phosphoproteins in Solid Tissues: The Reverse Phase Protein Array (RPPA) is a robust technique for quantitative proteomics, particularly useful for profiling post-translational modifications (PTMs) in finite tissue samples such as those from patients. Despite efforts to optimize tissue-based RPPA applications, technical challenges remain, including the validation of RPPA-applicable [...]

3D Bioprinted Breast Cancer Models for Enhanced Drug Testing and Metabolic Studies: Despite advancements in modeling the complex tumor microenvironment, conventional breast cancer models often fall short in providing accurate insights into cancer biology and drug efficacy. Accurately modeling this environment could improve the efficacy and safety of cancer treatments by offering more accurate preclinical [...]